NeuroMetrix, Inc. ( NURO) - Key Metrics
Stock symbol NURO is outdated, potentially delisted? Maybe it is available on other exchange?
NURO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.29 | -$0.75 | -$0.89 | -$0.89 |
| 2024Q2 | $0.38 | -$0.74 | -$0.68 | -$0.68 |
| 2024Q1 | $0.60 | -$1.67 | -$1.15 | -$1.15 |
| 2023Q4 | $0.86 | -$1.08 | -$0.95 | -$0.98 |
| 2023Q3 | $1.13 | -$1.66 | -$1.94 | -$2.07 |
NURO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -1.33 |
| 2024Q2 | ? | -1.22 |
| 2024Q1 | ? | -0.61 |
| 2023Q4 | ? | -0.83 |
| 2023Q3 | ? | -0.87 |
NURO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q3 | -22.32% | ? |
| 2024Q2 | -18.73% | ? |
| 2024Q1 | -28.29% | ? |
| 2023Q4 | -27.25% | ? |
| 2023Q3 | -35.86% | ? |
NURO
Price: $4.58
52 week price:
Earnings Per Share: -3.96 USD
P/E Ratio: -1.16
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 39500
Ebitda: -2.8 millionMarket Capitalization: 9.4 million